Frontlight ResearchEarly access
Trial site
Aomori
- 2running trials
- 5closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Chronic myeloid leukaemia3 trials
- Acute lymphoblastic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Lung cancer1 trial
- Multiple sclerosis1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 22 trials
- Phase 32 trials
- Status
- Completed5 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
Closed trials
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 12 Nov 2026